The Lakeside Healthcare Research and Innovation Unit has been set up to provide all our patients with the opportunity to take part in clinical research studies which are relevant to them.
Lakeside Healthcare Research and Innovation Unit
Novo Nordisk Zeus - A research study to look at how ziltivekimab works compared to placebo in people with cardiovascular disease, chronic kidney disease and inflammation.
Novartis Victorian - 1 Prevent - A randomized, double-blind, placebo-controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high-risk primary prevention patients
Moderna NextCove - A randomized, observer-blind, active-controlled Phase 3 study to investigate the safety and immunogenicity and relative vaccine efficacy of mRNA-1283.222 administered as a booster dose compared with mRNA1273.222 in participants aged 12 years and older for the prevention of COVID-19.
GSK RSV 0A=ADJ-012 - An extension and crossover vaccination study on the immune response and safety of a vaccine against respiratory syncytial virus given to adults 60 years of age and above who participated in RSV OA=ADJ-006 study. (Portfolio Studies)
Moderna Mpower mPox - A clinical trial of an investigational mpox vaccine, mRNA-1769-P101 for adults ages 18-C49.
Leo Pharma Adjust - Adjustable brodalumab dosage regimen compared with standard brodalumab treatment for 52 weeks in subjects with moderate-to-severe plaque psoriasis and ≥120 kg body weight.
Amgen Vesalius CV Study - A study looking at the efficacy of the drug Evolocumab (Repatha) is at lowering LDL-C in patients at risk of having a cardiovascular event.
GSK COPD PAS - A study looking at safety cardiovascular outcome data for two inhalers used in the management of COPD.
Novavax 2019nCoV-302 - A vaccine study looking at the efficacy of the Novavax Covid-19 vaccine in Adults in preventing serious Covid-19 Illness.
Valneva VLA2001-301 - A vaccine study looking at the efficacy of the Valneva Covid-19 vaccine in Adults in preventing serious Covid-19 Illness.
GSK RSV 006 - A vaccine study looking at the efficacy of a RSV (Respiratory Syncytial Virus) vaccine within older adults living in the community in preventing RSV infection.
AstraZeneca LOGOS study - An Asthma study looking at the effectiveness of new combined triple therapy inhaler in patients with inadequately controlled Asthma.
Boehringer Ingelheim 0022 CKD Study - A study for Chronic Kidney Disease looking at a new therapy to improve Kidney Function.
George Medicines GMRx2 - A clinical trial called GMRx2, single pill containing three widely used blood lowering drugs. Testing the efficacy and safety of GMRx2 compared to placebo for the treatment of hypertension.
Moderna CMVictory - A phase 3 vaccine study. Testing a new investigational vaccine (mRNA-1647) for its safety and effectiveness in preventing CMV in healthy adult females.
We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. You can find out more and set your own preferences here.